Oct 31, 2024 08:57PM
Sep 13, 2024 05:19PM
Jan 25, 2024 10:00AM
Jan 25, 2024 10:00AM
Oct 26, 2023 05:41PM
Oct 21, 2023 09:00AM
Sep 18, 2023 07:00AM ESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Apr 12, 2023 07:08AM
Apr 12, 2023 07:00AM
Mar 9, 2023 07:30AM
Feb 13, 2023 05:00PM
Dec 13, 2022 07:00AM
Nov 17, 2022 04:16PM
Oct 31, 2022 07:02AM ESSA Pharma (EPIX) Suspends Enrollment in Phase 1 Study of EPI-7386
Oct 31, 2022 07:00AM
Oct 26, 2022 07:02AM
Oct 26, 2022 07:00AM
Aug 4, 2022 07:00AM
Jun 27, 2022 04:01PM
Jun 27, 2022 04:01PM
May 10, 2022 07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2022
Feb 3, 2022 07:00AM
Jan 19, 2022 07:00AM
Nov 18, 2021 07:00AM
Oct 28, 2021 04:05PM
Oct 7, 2021 09:00AM
Oct 7, 2021 06:32AM
Oct 7, 2021 06:30AM Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling Collaboration
Aug 16, 2021 07:00AM
May 6, 2021 07:01AM
Apr 28, 2021 07:18AM
Apr 28, 2021 07:00AM
Apr 10, 2021 08:30AM
Feb 25, 2021 07:00AM
Feb 11, 2021 08:10AM ESSA Pharma Inc. (EPIX) Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
Feb 11, 2021 08:02AM
Feb 11, 2021 07:00AM
Jan 13, 2021 07:14AM
Jan 13, 2021 07:00AM
Dec 15, 2020 05:01PM
Nov 25, 2020 07:00AM
Nov 10, 2020 07:00AM ESSA Pharma to Participate in Upcoming Investor Conferences
Sep 21, 2020 07:00AM
Sep 14, 2020 07:12AM
Sep 14, 2020 07:00AM
Sep 10, 2020 07:00AM
Aug 6, 2020 08:00PM
Jul 31, 2020 10:16AM
Jul 29, 2020 05:50AM ESSA Pharma Inc. (EPIX) Prices 7.1M Share Common Offering at $6/Sh
Jul 28, 2020 09:18PM

322,096 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All